Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sanofi India has informed that the meeting of the Board of Directors of the Company will be held on Tuesday, 31st October 2017 to consider the unaudited financial results for the quarter ended 30th September 2017 (Q3).
The above information is a part of company’s filings submitted to BSE.